Soria JC - Search Results

1

A never-smoker lung adenocarcinoma patient with a MET exon 14 mutation (D1028N) and a rapid partial response after crizotinib.

Mahjoubi L, Gazzah A, Besse B, Lacroix L, Soria JC. Mahjoubi L, et al. Among authors: soria jc. Invest New Drugs. 2016 Jun;34(3):397-8. doi: 10.1007/s10637-016-0332-0. Epub 2016 Feb 18. Invest New Drugs. 2016. PMID: 26892698

2

Breast metastasis from lung adenocarcinoma: a case report.

Masmoudi A, Mathieu MC, Soria JC. Masmoudi A, et al. Among authors: soria jc. Anticancer Res. 2003 Mar-Apr;23(2C):1825-6. Anticancer Res. 2003. PMID: 12820464

3

Nuclear localization of apoptosis protease activating factor-1 predicts survival after tumor resection in early-stage non-small cell lung cancer.

Besse B, Candé C, Spano JP, Martin A, Khayat D, Le Chevalier T, Tursz T, Sabatier L, Soria JC, Kroemer G. Besse B, et al. Among authors: soria jc. Clin Cancer Res. 2004 Sep 1;10(17):5665-9. doi: 10.1158/1078-0432.CCR-04-0415. Clin Cancer Res. 2004. PMID: 15355891

4

[Predicting response to Iressa: unexpected mechanism].

Besse B, Le Chevalier T, Soria JC. Besse B, et al. Among authors: soria jc. Med Sci (Paris). 2004 Aug-Sep;20(8-9):750-1. doi: 10.1051/medsci/2004208-9750. Med Sci (Paris). 2004. PMID: 15361339 Free article. French. No abstract available.

5

[Oncogenes and thyroid tumors].

Lacroix L, Soria JC, Bidart JM, Schlumberger M. Lacroix L, et al. Among authors: soria jc. Bull Cancer. 2005 Jan;92(1):37-43. Bull Cancer. 2005. PMID: 15689324 Free article. Review. French.

6

Epidermal growth factor receptor, HER-2/neu and related pathways in lung adenocarcinomas with bronchioloalveolar features.

Erman M, Grunenwald D, Penault-Llorca F, Grenier J, Besse B, Validire P, Morat L, Girard P, Le Chevalier T, Sabatier L, Soria JC. Erman M, et al. Among authors: soria jc. Lung Cancer. 2005 Mar;47(3):315-23. doi: 10.1016/j.lungcan.2004.08.015. Lung Cancer. 2005. PMID: 15713515

7

Front-line doublets in advanced non-small cell lung cancer: The golden age for second line chemotherapy.

Besse B, Soria JC, Le Chevalier T. Besse B, et al. Among authors: soria jc. Ann Oncol. 2005 Jul;16(7):997-8. doi: 10.1093/annonc/mdi231. Epub 2005 Jun 9. Ann Oncol. 2005. PMID: 15946975 Free article. No abstract available.

8

Response of ovarian carcinomas to gefitinib-carboplatin-paclitaxel combination is not associated with EGFR kinase domain somatic mutations.

Lacroix L, Pautier P, Duvillard P, Motté N, Saulnier P, Bidart JM, Soria JC. Lacroix L, et al. Among authors: soria jc. Int J Cancer. 2006 Feb 15;118(4):1068-9. doi: 10.1002/ijc.21460. Int J Cancer. 2006. PMID: 16152583 Clinical Trial. No abstract available.

9

[EGFR-targeted therapies: what's new?].

Vignot S, Besse B, Soria JC, Milano G, Spano JP. Vignot S, et al. Among authors: soria jc. Bull Cancer. 2006 Jan;93(1):13-8. Bull Cancer. 2006. PMID: 16455501 Free article. Review. French.

10

Response to erlotinib in first-line treatment of non-small-cell lung cancer in a white male smoker with squamous-cell histology.

Achille M, Gallegos-Ruiz M, Giaccone G, Soria JC. Achille M, et al. Among authors: soria jc. Clin Lung Cancer. 2006 Nov;8(3):214-6. doi: 10.3816/CLC.2006.n.050. Clin Lung Cancer. 2006. PMID: 17239298

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

735 results

Search Page

Filters